Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Mar;64(Suppl 2):ii14–ii17. doi: 10.1136/ard.2004.032482

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

D Gladman, C Antoni, P Mease, D Clegg, P Nash
PMCID: PMC1766874  PMID: 15708927

Abstract

Psoriatic arthritis (PsA) has been defined as a unique inflammatory arthritis associated with psoriasis. Its exact prevalence is unknown, but estimates vary from 0.3% to 1% of the population. The clinical features described initially are recognised by most experienced clinicians, although they are most distinct in early disease. Initially, PsA typically presents as an oligoarticular and mild disease. However, with time PsA becomes polyarticular, and it is a severe disease in at least 20% of patients. Patients with PsA who present with polyarticular disease are at risk for disease progression. In addition to progression of clinical and radiological damage, health related quality of life is reduced among patients with PsA. It important to note that patients included in recent drug trials resemble patients followed prospectively in a clinic.

Full Text

The Full Text of this article is available as a PDF (66.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackmore M. G., Gladman D. D., Husted J., Long J. A., Farewell V. T. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol. 1995 May;22(5):886–893. [PubMed] [Google Scholar]
  2. Cats A. Psoriasis and arthritis. Cutis. 1990 Oct;46(4):323–329. [PubMed] [Google Scholar]
  3. Clegg D. O., Reda D. J., Mejias E., Cannon G. W., Weisman M. H., Taylor T., Budiman-Mak E., Blackburn W. D., Vasey F. B., Mahowald M. L. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum. 1996 Dec;39(12):2013–2020. doi: 10.1002/art.1780391210. [DOI] [PubMed] [Google Scholar]
  4. Eastmond C. J., Wright V. The nail dystrophy of psoriatic arthritis. Ann Rheum Dis. 1979 Jun;38(3):226–228. doi: 10.1136/ard.38.3.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gladman D. D., Anhorn K. A., Schachter R. K., Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol. 1986 Jun;13(3):586–592. [PubMed] [Google Scholar]
  6. Gladman D. D. Clinical aspects of the spondyloarthropathies. Am J Med Sci. 1998 Oct;316(4):234–238. doi: 10.1097/00000441-199810000-00003. [DOI] [PubMed] [Google Scholar]
  7. Gladman D. D., Farewell V. T., Kopciuk K. A., Cook R. J. HLA markers and progression in psoriatic arthritis. J Rheumatol. 1998 Apr;25(4):730–733. [PubMed] [Google Scholar]
  8. Gladman D. D., Farewell V. T., Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol. 1995 Apr;22(4):675–679. [PubMed] [Google Scholar]
  9. Gladman D. D., Farewell V. T. Progression in psoriatic arthritis: role of time varying clinical indicators. J Rheumatol. 1999 Nov;26(11):2409–2413. [PubMed] [Google Scholar]
  10. Gladman D. D., Farewell V. T., Wong K., Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum. 1998 Jun;41(6):1103–1110. doi: 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  11. Gladman D. D., Hing E. N., Schentag C. T., Cook R. J. Remission in psoriatic arthritis. J Rheumatol. 2001 May;28(5):1045–1048. [PubMed] [Google Scholar]
  12. Gladman D. D. Psoriatic arthritis. Baillieres Clin Rheumatol. 1995 May;9(2):319–329. doi: 10.1016/s0950-3579(05)80193-1. [DOI] [PubMed] [Google Scholar]
  13. Gladman D. D., Shuckett R., Russell M. L., Thorne J. C., Schachter R. K. Psoriatic arthritis (PSA)--an analysis of 220 patients. Q J Med. 1987 Feb;62(238):127–141. [PubMed] [Google Scholar]
  14. Helliwell P. S., Taylor W. J. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis. 2005 Mar;64 (Suppl 2):ii3–ii8. doi: 10.1136/ard.2004.032318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Helliwell P., Marchesoni A., Peters M., Barker M., Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol. 1991 Oct;30(5):339–345. doi: 10.1093/rheumatology/30.5.339. [DOI] [PubMed] [Google Scholar]
  16. Husted J. A., Gladman D. D., Cook R. J., Farewell V. T. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. J Rheumatol. 1998 Nov;25(11):2146–2155. [PubMed] [Google Scholar]
  17. Husted J. A., Gladman D. D., Farewell V. T., Cook R. J. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001 Apr;45(2):151–158. doi: 10.1002/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  18. Husted J. A., Gladman D. D., Farewell V. T., Long J. A., Cook R. J. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol. 1997 Mar;24(3):511–517. [PubMed] [Google Scholar]
  19. Husted J. A., Gladman D. D., Long J. A., Farewell V. T. A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol. 1995 Jul-Aug;13(4):439–443. [PubMed] [Google Scholar]
  20. Jones S. M., Armas J. B., Cohen M. G., Lovell C. R., Evison G., McHugh N. J. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol. 1994 Sep;33(9):834–839. doi: 10.1093/rheumatology/33.9.834. [DOI] [PubMed] [Google Scholar]
  21. Kaltwasser J. Peter, Nash Peter, Gladman Dafna, Rosen Cheryl F., Behrens Frank, Jones Peter, Wollenhaupt Jürgen, Falk Franziska G., Mease Philip, Treatment of Psoriatic Arthritis Study Group Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum. 2004 Jun;50(6):1939–1950. doi: 10.1002/art.20253. [DOI] [PubMed] [Google Scholar]
  22. Kammer G. M., Soter N. A., Gibson D. J., Schur P. H. Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum. 1979 Nov;9(2):75–97. doi: 10.1016/s0049-0172(79)80001-3. [DOI] [PubMed] [Google Scholar]
  23. Kane D., Stafford L., Bresnihan B., FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003 Oct 1;42(12):1460–1468. doi: 10.1093/rheumatology/keg384. [DOI] [PubMed] [Google Scholar]
  24. Marsal S., Armadans-Gil L., Martínez M., Gallardo D., Ribera A., Lience E. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 1999 Apr;38(4):332–337. doi: 10.1093/rheumatology/38.4.332. [DOI] [PubMed] [Google Scholar]
  25. McHugh N. J., Balachrishnan C., Jones S. M. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003 Mar 14;42(6):778–783. doi: 10.1093/rheumatology/keg217. [DOI] [PubMed] [Google Scholar]
  26. McKenna S. P., Doward L. C., Whalley D., Tennant A., Emery P., Veale D. J. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis. 2004 Feb;63(2):162–169. doi: 10.1136/ard.2003.006296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mease P. J., Goffe B. S., Metz J., VanderStoep A., Finck B., Burge D. J. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000 Jul 29;356(9227):385–390. doi: 10.1016/S0140-6736(00)02530-7. [DOI] [PubMed] [Google Scholar]
  28. Mease Philip J., Kivitz Alan J., Burch Francis X., Siegel Evan L., Cohen Stanley B., Ory Peter, Salonen David, Rubenstein Joel, Sharp John T., Tsuji Wayne. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum. 2004 Jul;50(7):2264–2272. doi: 10.1002/art.20335. [DOI] [PubMed] [Google Scholar]
  29. O'Neill T., Silman A. J. Psoriatic arthritis. Historical background and epidemiology. Baillieres Clin Rheumatol. 1994 May;8(2):245–261. doi: 10.1016/s0950-3579(94)80017-0. [DOI] [PubMed] [Google Scholar]
  30. Olivieri I., Barozzi L., Pierro A., De Matteis M., Padula A., Pavlica P. Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. J Rheumatol. 1997 May;24(5):926–930. [PubMed] [Google Scholar]
  31. Ory Peter A. Radiography in the assessment of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2003 Jun;17(3):495–512. doi: 10.1016/s1521-6942(03)00022-6. [DOI] [PubMed] [Google Scholar]
  32. Queiro-Silva R., Torre-Alonso J. C., Tinturé-Eguren T., López-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis. 2003 Jan;62(1):68–70. doi: 10.1136/ard.62.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rahman P., Elder J. T. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2005 Mar;64 (Suppl 2):ii37–ii41. doi: 10.1136/ard.2004.030775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rahman P., Nguyen E., Cheung C., Schentag C. T., Gladman D. D. Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol. 2001 May;28(5):1041–1044. [PubMed] [Google Scholar]
  35. Roberts M. E., Wright V., Hill A. G., Mehra A. C. Psoriatic arthritis. Follow-up study. Ann Rheum Dis. 1976 Jun;35(3):206–212. doi: 10.1136/ard.35.3.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Savolainen Elina, Kaipiainen-Seppänen Oili, Kröger Liisa, Luosujärvi Riitta. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol. 2003 Nov;30(11):2460–2468. [PubMed] [Google Scholar]
  37. Scarpa R., Oriente P., Pucino A., Torella M., Vignone L., Riccio A., Biondi Oriente C. Psoriatic arthritis in psoriatic patients. Br J Rheumatol. 1984 Nov;23(4):246–250. doi: 10.1093/rheumatology/23.4.246. [DOI] [PubMed] [Google Scholar]
  38. Shbeeb M., Uramoto K. M., Gibson L. E., O'Fallon W. M., Gabriel S. E. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol. 2000 May;27(5):1247–1250. [PubMed] [Google Scholar]
  39. Sokoll K. B., Helliwell P. S. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol. 2001 Aug;28(8):1842–1846. [PubMed] [Google Scholar]
  40. Söderlin M. K., Börjesson O., Kautiainen H., Skogh T., Leirisalo-Repo M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis. 2002 Oct;61(10):911–915. doi: 10.1136/ard.61.10.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Thorstensson C. A., Petersson I. F., Jacobsson L. T. H., Boegård T. L., Roos E. M. Reduced functional performance in the lower extremity predicted radiographic knee osteoarthritis five years later. Ann Rheum Dis. 2004 Apr;63(4):402–407. doi: 10.1136/ard.2003.007583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Torre Alonso J. C., Rodriguez Perez A., Arribas Castrillo J. M., Ballina Garcia J., Riestra Noriega J. L., Lopez Larrea C. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol. 1991 Aug;30(4):245–250. doi: 10.1093/rheumatology/30.4.245. [DOI] [PubMed] [Google Scholar]
  43. Trabace S., Cappellacci S., Ciccarone P., Liaskos S., Polito R., Zorzin L. Psoriatic arthritis: a clinical, radiological and genetic study of 58 Italian patients. Acta Derm Venereol Suppl (Stockh) 1994;186:69–70. [PubMed] [Google Scholar]
  44. Veale D., Rogers S., Fitzgerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol. 1994 Feb;33(2):133–138. doi: 10.1093/rheumatology/33.2.133. [DOI] [PubMed] [Google Scholar]
  45. Wong K., Gladman D. D., Husted J., Long J. A., Farewell V. T. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum. 1997 Oct;40(10):1868–1872. doi: 10.1002/art.1780401021. [DOI] [PubMed] [Google Scholar]
  46. Zachariae Hugh. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003;4(7):441–447. doi: 10.2165/00128071-200304070-00001. [DOI] [PubMed] [Google Scholar]
  47. Zachariae Hugh, Zachariae Robert, Blomqvist Kirsti, Davidsson Steingrimur, Molin Lars, Mørk Cato, Sigurgeirsson Bardur. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol. 2002;82(2):108–113. doi: 10.1080/00015550252948130. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES